Insider trades

Kathryn E. Falberg, Director of Arcus Biosciences RCUS, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $4.7M. The latest trade was on 06/11.

Kathryn E. Falberg

Director
First filing
23/02/08
Trades
38 trades
Buys / sales
0 / 5
12-month net buying
−$4.7M
Last trade
06/11

Trading activity

Transactions

Trade type
TTD
Open-market sale03/0503/09152,828 sh2 trades$30.46avg.$4,655,112.6No record
Open-market sale24/08/1324/08/15150,000 sh$98.17$14,725,500−60.8%
TTD
Open-market sale24/03/0824/03/12103,030 sh2 trades$81.90avg.$8,438,200.7−29.8%